Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers

NANot yet recruitingINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

March 30, 2027

Conditions

Diabetic Foot Ulcer

Interventions

DEVICE

Omeza® Complete Matrix

OCM Application, Surgical sharp debridement, offloading (TCC gold standard, fixed ankle-walker alternative), and proper moisture balance

OTHER

Standard of Care

Surgical sharp debridement, offloading (TCC gold standard, fixed ankle-walker alternative), and proper moisture balance

All Listed Sponsors

collaborator

SygNola, LLC

INDUSTRY

lead

Omeza, LLC

INDUSTRY

NCT07161830 - Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter